Beijing Tong Ren Tang Chinese Medicine Sustainability Profile
Beijing Tong Ren Tang Chinese Medicine, often referred to simply as Tong Ren Tang, is a renowned leader in the traditional Chinese medicine industry. Headquartered in Beijing, China, the company has expanded its operations across various regions, including Asia, Europe, and North America. Founded in 1669, Tong Ren Tang has a rich history marked by significant milestones, including its establishment as a royal pharmacy during the Qing Dynasty. Specialising in herbal medicine, acupuncture, and wellness products, Tong Ren Tang is celebrated for its commitment to quality and authenticity. Its core offerings include traditional Chinese herbal remedies and proprietary formulations, which are distinguished by their adherence to time-honoured practices and rigorous quality control. With a strong market position, Tong Ren Tang has garnered numerous accolades, solidifying its reputation as a trusted name in holistic health and wellness.
DitchCarbon Score
How does Beijing Tong Ren Tang Chinese Medicine's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Tong Ren Tang Chinese Medicine's score of 29 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Tong Ren Tang Chinese Medicine's reported carbon emissions
In 2022, Beijing Tong Ren Tang Chinese Medicine reported total carbon emissions of approximately 1,957,000 kg CO2e. This figure includes Scope 1 emissions of about 1,100 kg CO2e and Scope 2 emissions of approximately 124,400 kg CO2e. Notably, there is no reported data for Scope 3 emissions. Comparatively, in 2021, the company’s total emissions were approximately 2,058,300 kg CO2e, with Scope 1 emissions at about 1,300 kg CO2e and Scope 2 emissions at approximately 104,900 kg CO2e. This indicates a reduction in total emissions from 2021 to 2022. Despite these reductions, there are currently no documented reduction targets or climate pledges from Beijing Tong Ren Tang Chinese Medicine. The company does not appear to have cascaded emissions data from a parent organization, and all reported figures are directly from their own disclosures. Overall, while the company has made strides in reducing its emissions, further commitments and transparency regarding climate initiatives would enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 113,100 | - | 0,000,000 | 0,000 | 0,000 |
| Scope 2 | 2,267,400 | - | 0,000,000 | 000,000 | 000,000 |
| Scope 3 | 184,700 | - | - | - | - |
How Carbon Intensive is Beijing Tong Ren Tang Chinese Medicine's Industry?
How Carbon Intensive is Beijing Tong Ren Tang Chinese Medicine's Location?
Beijing Tong Ren Tang Chinese Medicine's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 7% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Top Scope 3 Categories
Beijing Tong Ren Tang Chinese Medicine's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Beijing Tong Ren Tang Chinese Medicine has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Hunan Er-Kang Pharmaceutical Co., Ltd
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.